Compare Adobe Systems Inc (ADBE) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adobe Systems Inc vs Medpace Holdings Inc — how do they compare? Adobe Systems Inc trades at $261 (market cap $104.82B), while Medpace Holdings Inc trades at $598 (market cap $16.90B). The key difference: Adobe Systems Inc is far larger — about 6.2× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Adobe Systems Inc nearer its low. Which is the better fit depends on your goals.
| ADBE | MEDP | |
|---|---|---|
Market Cap | $104.82B | $16.90B |
Volume | 5,187,646 | — |
Sector | Technology | Technology |
52-Week High | $367.46 | $620.59 |
52-Week Low | $193.41 | $393.42 |
Enterprise Value | $106.26B | $16.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe Inc. (ADBE) trades at $263.71, down 3.39% over 24 hours, amid mixed market sentiment. The stock exhibits strong fundamentals with consistent earnings beats, robust profitability margins, and healthy revenue growth. Technical indicators show a bullish trend with key support at $261 and resistance at $269. Recent news highlights institutional buying activity but also AI competition concerns and a CEO transition.
Outlook remains positive given solid financials and growth trajectory, though risks include AI disruption fears and market volatility. The stock presents a value opportunity with a P/E of 15.09, below historical averages, supported by a 49.2% analyst buy rating. Investors should weigh strong cash flows against competitive and execution risks.
MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.
MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
